Please provide your email address to receive an email when new articles are posted on . In a human challenge trial, the GA2 vaccine prevented 89% of people who received it from being infected with ...
Hosted on MSN
Next-gen flu vaccines use proteolysis-targeting to boost safety and cross-strain immunity in animal models
Recently, Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a library of live-attenuated influenza A vaccines that utilize ...
A new, two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and ...
A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop ...
Please provide your email address to receive an email when new articles are posted on . Most transplant recipients developed and maintained protective antibodies up to 1 year after varicella or MMR ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback